Repotrectinib in ROS1 Fusion-Positive Non-Small-Cell Lung Cancer. Drilon A, Camidge DR, Lin JJ, Kim SW, et al. N Engl J Med 2024;390:118-131.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Drilon A, Camidge DR, Lin JJ, Kim SW, et al. Repotrectinib in ROS1 Fusion-Positive Non-Small-Cell Lung Cancer. N Engl J Med 2024;390:118-131.
PMID: 38197815